Works matching IS 14628902 AND DT 2025

Results: 445
    1
    2

    Management of metabolic dysfunction–associated steatotic liver disease (MASLD)—An expert consensus statement from Indian diabetologists' perspective.

    Published in:
    Diabetes, Obesity & Metabolism, 2025, v. 27, p. 3, doi. 10.1111/dom.16496
    By:
    • Zargar, Abdul Hamid;
    • Bhansali, Anil;
    • Majumdar, Anirban;
    • Maheshwari, Anuj;
    • Bhattacharyya, Arpandev;
    • Dasgupta, Arundhati;
    • Saboo, Banshi Damodarlal;
    • Sethi, Bipin Kumar;
    • Sanyal, Debmalya;
    • Seshadri, Krishna G.;
    • Deshpande, Neeta Rohit;
    • Kapoor, Nitin;
    • Lakhani, Om Jitendra;
    • Talwalkar, Pradeep Gopal;
    • Kalra, Pramila;
    • Mehrotra, Rabindera Nath;
    • Sahay, Rakesh Kumar;
    • Shukla, Rishi;
    • Kant, Saket;
    • Das, Sambit
    Publication type:
    Article
    3

    Front Cover.

    Published in:
    Diabetes, Obesity & Metabolism, 2025, v. 27, n. 7, p. C1, doi. 10.1111/dom.16537
    By:
    • Lala, Anuradha;
    • Levin, Adeera;
    • Khunti, Kamlesh
    Publication type:
    Article
    4
    5
    6
    7

    Fasting and postprandial kidney haemodynamic effects of empagliflozin and linagliptin in mono‐ and combination therapy compared to gliclazide in overweight people with type 2 diabetes (RACELINES): A randomised, double‐blind trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2025, v. 27, n. 7, p. 3943, doi. 10.1111/dom.16431
    By:
    • van Baar, Michaël J. B.;
    • Muskiet, Marcel H. A.;
    • Scholtes, Rosalie A.;
    • Touw, Daan J.;
    • Nieuwdorp, Max;
    • Kramer, Mark H. H.;
    • Joles, Jaap A.;
    • Cherney, David Z. I.;
    • Bjornstad, Petter;
    • Krebber, Merle M.;
    • van Raalte, Daniël H.
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17

    Social disadvantage and technology use among adults with type 1 diabetes in Quebec: A cross‐sectional study using data from the Canadian T1D (BETTER) Registry.

    Published in:
    Diabetes, Obesity & Metabolism, 2025, v. 27, n. 7, p. 3921, doi. 10.1111/dom.16426
    By:
    • Khodabandehloo, Parisa;
    • Fakembe, Patience;
    • Senga, Joyeuse;
    • Shulman, Rayzel;
    • Lipscombe, Lorraine L.;
    • Witteman, Holly O.;
    • Banerjee, Ananya;
    • Presseau, Justin;
    • Nakhla, Meranda;
    • Dogba, Maman Joyce;
    • Lovblom, Leif Erik;
    • Rabasa‐Lhoret, Rémi;
    • Brazeau, Anne‐Sophie;
    • Najam, Adhiyat;
    • Cheema, Wajeeha;
    • MacGibbon, Christine;
    • Weisman, Alanna
    Publication type:
    Article
    18
    19
    20
    21
    22

    Proposed minimum requirements for market approval of continuous glucose monitoring (CGM) systems: A viewpoint from the IFCC working group on CGM.

    Published in:
    Diabetes, Obesity & Metabolism, 2025, v. 27, n. 7, p. 4039, doi. 10.1111/dom.16420
    By:
    • Pleus, Stefan;
    • Eichenlaub, Manuel;
    • Eriksson Boija, Elisabet;
    • Diem, Peter;
    • Fokkert, Marion;
    • Hinzmann, Rolf;
    • Jendle, Johan;
    • Klonoff, David C.;
    • Makris, Konstantinos;
    • Nichols, James H.;
    • Pemberton, John;
    • Selvin, Elizabeth;
    • Slingerland, Robbert J.;
    • Thomas, Andreas;
    • Tran, Nam K.;
    • Witthauer, Lilian;
    • Freckmann, Guido
    Publication type:
    Article
    23

    Liraglutide improves peripheral perfusion and markers of angiogenesis and inflammation in people with type 2 diabetes and peripheral artery disease: An 18‐month follow‐up of a randomized clinical trial.

    Published in:
    Diabetes, Obesity & Metabolism, 2025, v. 27, n. 7, p. 3891, doi. 10.1111/dom.16419
    By:
    • Caruso, Paola;
    • Maiorino, Maria Ida;
    • Longo, Miriam;
    • Maio, Antonietta;
    • Scappaticcio, Lorenzo;
    • Di Martino, Nicole;
    • Carbone, Carla;
    • Barrasso, Mariluce;
    • Caputo, Mariangela;
    • Gicchino, Maurizio;
    • Bellastella, Giuseppe;
    • Giugliano, Dario;
    • Esposito, Katherine
    Publication type:
    Article
    24
    25
    26

    Clinically meaningful improvements in treatment satisfaction in insulin‐naïve people with type 2 diabetes post initiation of insulin glargine 300 U/mL: A post hoc analysis of real‐world ATOS study.

    Published in:
    Diabetes, Obesity & Metabolism, 2025, v. 27, n. 7, p. 4011, doi. 10.1111/dom.16415
    By:
    • Snoek, Frank;
    • Galstyan, Gagik;
    • Khan, Niaz;
    • Tirosh, Amir;
    • Kesavadev, Jothydev;
    • Vargas‐Uricoechea, Hernando;
    • Baghous, Houssem;
    • Mabunay, Maria Aileen;
    • Grulovic, Natasa;
    • Corp dit Genti, Valerie;
    • Msihid, Jerome;
    • Harris, Stewart
    Publication type:
    Article
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50